Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03815682
Title RPTR-147 in Patients With Selected Solid Tumors and Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Repertoire Immune Medicines
Indications

lymphoma

melanoma

lung non-small cell carcinoma

clear cell renal cell carcinoma

head and neck squamous cell carcinoma

transitional cell carcinoma

sarcoma

Advanced Solid Tumor

ovarian cancer

Therapies

Pembrolizumab + RPTR-147

RPTR-147

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.